John Wiley & Sons Inc
NYSE:WLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
John Wiley & Sons Inc
NYSE:WLY
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
|
Sword Group SE
PAR:SWP
|
LU |
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
CA |
|
Philex Mining Corp
OTC:PXMFF
|
PH |
|
N
|
Novo Nordisk A/S
XMUN:NOV
|
DK |
|
C
|
Condor Gold PLC
TSX:COG
|
UK |
|
A
|
Adtalem Global Education Inc
DUS:DVY
|
US |
Intrinsic Value
The intrinsic value for John Wiley & Sons Inc (WLY) under the Base Case is hidden
USD.
Compared with the current market price of 44.08 USD, the stock appears hidden
.
WLY looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if WLY is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for John Wiley & Sons Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
John Wiley & Sons Inc
Earnings Waterfall
John Wiley & Sons Inc
The intrinsic value for John Wiley & Sons Inc (WLY) under the Base Case is hidden USD.
Compared with the current market price of 44.08 USD, the stock appears hidden.
